SICHUAN KELUN-BIOTECH BIOPHARMACEUT revenue breakdown overview

SICHUAN KELUN-BIOTECH BIOPHARMACEUT revenue for the last year amounted to 2.06 B HKD, the most of which — 2.10 B HKD — came from its highest performing source at the moment, Novel Drugs, the year earlier bringing 1.70 B HKD. The greatest contribution to the revenue figure was made by United States — last year it brought SICHUAN KELUN-BIOTECH BIOPHARMACEUT 2.00 B HKD, and the year before that — 1.69 B HKD.